• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci China Life Sci . Longitudinal virological changes and underlying pathogenesis in hospitalized COVID-19 patients in Guangzhou, China

tetano

Editor, Senior Moderator
Sci China Life Sci


. 2021 Apr 28.
doi: 10.1007/s11427-020-1921-5. Online ahead of print.
Longitudinal virological changes and underlying pathogenesis in hospitalized COVID-19 patients in Guangzhou, China


Zhengtu Li[SUP] #[/SUP][SUP] 1 [/SUP], Yinhu Li[SUP] #[/SUP][SUP] 2 [/SUP], Ruilin Sun[SUP] #[/SUP][SUP] 3 [/SUP], Shaoqiang Li[SUP] #[/SUP][SUP] 1 [/SUP], Lingdan Chen[SUP] #[/SUP][SUP] 1 [/SUP], Yangqing Zhan[SUP] #[/SUP][SUP] 1 [/SUP], Mingzhou Xie[SUP] 4 [/SUP], Jiasheng Yang[SUP] 3 [/SUP], Yanqun Wang[SUP] 1 [/SUP], Airu Zhu[SUP] 1 [/SUP], Guoping Gu[SUP] 1 [/SUP], Le Yu[SUP] 4 [/SUP], Shuaicheng Li[SUP] 2 [/SUP], Tingting Liu[SUP] 4 [/SUP], Zhaoming Chen[SUP] 1 [/SUP], Wenhua Jian[SUP] 1 [/SUP], Qian Jiang[SUP] 1 [/SUP], Xiaofen Su[SUP] 1 [/SUP], Weili Gu[SUP] 1 [/SUP], Liyan Chen[SUP] 1 [/SUP], Jing Cheng[SUP] 1 [/SUP], Jincun Zhao[SUP] 1 [/SUP], Wenju Lu[SUP] 1 [/SUP], Jinping Zheng[SUP] 1 [/SUP], Shiyue Li[SUP] 1 [/SUP], Nanshan Zhong[SUP] 1 [/SUP], Feng Ye[SUP] 5 [/SUP]



Affiliations

Abstract

Prolonged viral RNA shedding and recurrence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in coronavirus disease 2019 (COVID-19) patients have been reported. However, the clinical outcome and pathogenesis remain unclear. In this study, we recruited 43 laboratory-confirmed COVID-19 patients. We found that prolonged viral RNA shedding or recurrence mainly occurred in severe/critical patients (P<0.05). The average viral shedding time in severe/critical patients was more than 50 days, and up to 100 days in some patients, after symptom onset. However, chest computed tomography gradually improved and complete absorption occurred when SARS-CoV-2 RT-PCR was still positive, but specific antibodies appeared. Furthermore, the viral shedding time significantly decreased when the A1,430G or C12,473T mutation occurred (P<0.01 and FDR<0.01) and increased when G227A occurred (P<0.05 and FDR<0.05). High IL1R1, IL1R2, and TNFRSF21 expression in the host positively correlated with viral shedding time (P<0.05 and false discovery rate <0.05). Prolonged viral RNA shedding often occurs but may not increase disease damage. Prolonged viral RNA shedding is associated with viral mutations and host factors.

Keywords: SRAS-CoV-2; host gene expression; longitudinal virological changes; viral genome
 
Back
Top Bottom